On February 2, 2022 Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in transforming disease management and improving patient outcomes through innovative diagnostics, reported that it has received a 2022 Top Workplaces USA award from Energage (Press release, Castle Biosciences, FEB 2, 2022, View Source [SID1234607642]). The Top Workplaces USA award celebrates organizations with 150 or more U.S. employees that have built exceptional workplace cultures. Recipients of the Top Workplaces USA award are chosen solely on employee feedback gathered through an employee engagement survey.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"From the beginning, we have strived to create something different at Castle – a place where we make decisions based on what is best for people: the patients who benefit from the information that our advanced diagnostic tests provide; the clinicians who use our tests to inform their disease management decisions; and our employees, the valued members of our Castle family," said Derek Maetzold, president and chief executive officer of Castle Biosciences. "We are incredibly honored to have received the Top Workplaces USA award, and credit our fantastic employees, who embody our values of integrity, transparency, collaboration and innovation. At Castle, we understand that the true value of our company comes from our talented employees and believe that our focus on maintaining a positive culture helps us attract top talent, people who are willing to go the extra mile to make a difference in patient care."
Castle has received numerous awards recognizing its strong company culture, innovation, leadership and overall company performance. Recent awards include: Inc.’s Best-Led Companies of 2021; the Houston Chronicle’s 2021 Top Workplaces; the Houston Chronicle’s "CHRON 100" list of the 100 most successful publicly traded companies in Houston in 2020 and 2021; a 2021 MedTech Breakthrough Award for the "Best New Technology Solution for Oncology" recognizing the Company’s DecisionDx-SCC and DecisionDx DiffDx-Melanoma gene expression profile tests; a Healthcare Technology Report Top 100 Healthcare Technology Company in 2021; and a 2019 Technology Innovation in Melanoma Award from the American Skin Association.